Cian Healthcare has dispatched a letter to shareholders providing the web link to access the notice for its 23rd Annual General Meeting (AGM) and the Annual Report for FY26. The company informed the BSE on September 5, 2026, regarding this disclosure under SEBI Listing Regulations.

The 23rd AGM is scheduled for Tuesday, September 29, 2026, at 11:00 am through Video Conferencing/Other Audio-Visual Means (VC/OAVM). The remote e-voting facility will commence on Saturday, September 26, 2026, at 9:00 am and conclude on Monday, September 28, 2026, at 5:00 pm. The cut-off date for determining member eligibility to vote is Thursday, September 24, 2026.

Accessing Documents

Shareholders can access the AGM notice and the Annual Report for the Financial Year 2025-26 via the company’s website. The documents are available at the following paths:

• Notice: www.cian.co > Investor Relations > Corporate Announcements > Corporate Announcements 2026 > Notice of 23rd Annual General Meeting
• Annual Report: www.cian.co > Investor Relations > Financial Information > Annual Reports > Annual Report - FY 2025-26

Physical copies of the Annual Report will not be dispatched unless specifically requested by members. The documents are also accessible on the BSE Limited website and the Registrar and Share Transfer Agent’s website.

Auditor Appointments

During a board meeting held in New Delhi on September 2, 2026, the company filled the casual vacancy at the office of statutory auditors following the resignation of M/s S S R C A & Co. M/s Rasool Singhal & Co., Chartered Accountants (Firm Registration No. 500015N), was appointed to hold office until the ensuing AGM.

M/s N D M & Company, Chartered Accountants (Firm Registration No. 036038N), was appointed as internal auditors for FY27. Both appointments followed recommendations from the Audit Committee.

Employee Stock Option Scheme

The board recommended the Employee Stock Option Scheme, 2026, for shareholder approval. The plan contemplates granting up to 1,00,00,000 employee stock options to eligible employees of the company and its group entities.

Key terms include:

• Exercise price decided by the Compensation Committee, not less than face value
• Minimum vesting period of one year from grant date
• Maximum exercise period of five years from vesting date
• Administration by the Nomination and Remuneration Committee

No options have been granted under the scheme as of the meeting date.

AGM and E-Voting Details

The company published newspaper advertisements in Financial Express and Loksatta on September 4, 2026, regarding the AGM notice. Members can participate in the meeting via VC/OAVM without physical presence. Bigshare Services Private Limited has been appointed to provide e-voting facilities.

Members who acquire shares after the dispatch of the notice but hold shares as on the cut-off date must refer to the AGM notice for login credentials. A scrutinizer, Ms. Diya Rani of M/s Diya Rani & Associates, has been appointed to oversee the e-voting process.

Shareholder Compliance

The company reminded shareholders that it is mandatory to update PAN, KYC details, and nomination information with their Depository Participants. Payments, including dividends, for folios where PAN or KYC details are not updated will only be made electronically upon registration of the required information.

Cian Healthcare Limited’s Audit Committee has formally noted the resignation of its statutory auditors, M/s S S R C A & Co., effective August 27, 2026.

The Committee met on September 2, 2026, to review the resignation letter submitted by the auditors. It confirmed that there were no concerns or qualifications that prompted the departure and stated that no material reasons exist beyond those explicitly cited in the resignation notice.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Rachit Malhotra, Company Secretary and Chief Compliance Officer, signed the filing on behalf of the company. The Audit Committee has recommended the matter to the Board of Directors for further deliberation and noting.

The company is an ISO 9001:2015 and WHO GMP certified entity. The filing does not disclose the appointment of a replacement auditor at this stage.